double top breakdown observed in sunpharma.
breakdown validated with volume.
Next support/target 950
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
